• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于 Caprini 评分的静脉血栓栓塞风险分类的系统评价。

Systematic review of venous thromboembolism risk categories derived from Caprini score.

机构信息

Department of Vascular Surgery, University of Maryland, Baltimore, MD; Surgery Service, VA Medical Center, Baltimore, MD.

Department of Vascular Surgery, University of Maryland, Baltimore, MD.

出版信息

J Vasc Surg Venous Lymphat Disord. 2022 Nov;10(6):1401-1409.e7. doi: 10.1016/j.jvsv.2022.05.003. Epub 2022 Aug 2.

DOI:10.1016/j.jvsv.2022.05.003
PMID:35926802
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9783939/
Abstract

OBJECTIVE

Hospital-acquired venous thromboembolism (VTE, including pulmonary embolism [PE] and deep vein thrombosis [DVT]) is a preventable cause of hospital death. The Caprini risk assessment model (RAM) is one of the most commonly used tools to assess VTE risk. The RAM is operationalized in clinical practice by grouping several risk scores into VTE risk categories that drive decisions on prophylaxis. A correlation between increasing Caprini scores and rising VTE risk is well-established. We assessed whether the increasing VTE risk categories assigned on the basis of recommended score ranges also correlate with increasing VTE risk.

METHODS

We conducted a systematic review of articles that used the Caprini RAM to assign VTE risk categories and that reported corresponding VTE rates. A Medline and EMBASE search retrieved 895 articles, of which 57 fulfilled inclusion criteria.

RESULTS

Forty-eight (84%) of the articles were cohort studies, 7 (12%) were case-control studies, and 2 (4%) were cross-sectional studies. The populations varied from postsurgical to medical patients. There was variability in the number of VTE risk categories assigned by individual studies (6 used 5 risk categories, 37 used 4, 11 used 3, and 3 used 2), and in the cutoff scores defining the risk categories (scores from 0 alone to 0-10 for the low-risk category; from ≥5 to ≥10 for high risk). The VTE rates reported for similar risk categories also varied across studies (0%-12.3% in the low-risk category; 0%-40% for high risk). The Caprini RAM is designed to assess composite VTE risk; however, two studies reported PE or DVT rates alone, and many of the other studies did not specify the types of DVTs analyzed. The Caprini RAM predicts VTE at 30 days after assessment; however, only 17 studies measured outcomes at 30 days; the remaining studies had either shorter or longer follow-ups (0-180 days).

CONCLUSIONS

The usefulness of the Caprini RAM is limited by heterogeneity in its implementation across centers. The score-derived VTE risk categorization has significant variability in the number of risk categories being used, the cutpoints used to define the risk categories, the outcome being measured, and the follow-up duration. This factor leads to similar risk categories being associated with different VTE rates, which impacts the clinical and research implications of the results. To enhance generalizability, there is a need for studies that validate the RAM in a broad population of medical and surgical patients, identify standardized risk categories, define risk of DVT and PE as distinct end points, and measure outcomes at standardized follow-up time points.

摘要

目的

医院获得性静脉血栓栓塞症(VTE,包括肺栓塞[PE]和深静脉血栓形成[DVT])是医院死亡的可预防原因。卡普里尼风险评估模型(RAM)是评估 VTE 风险最常用的工具之一。RAM 通过将几个风险评分分组为 VTE 风险类别来在临床实践中实施,这些类别可驱动预防决策。卡普里尼评分的增加与 VTE 风险的增加之间存在相关性已得到充分证实。我们评估了基于推荐评分范围分配的风险类别增加是否与 VTE 风险增加相关。

方法

我们对使用卡普里尼 RAM 分配 VTE 风险类别并报告相应 VTE 发生率的文章进行了系统评价。对 Medline 和 EMBASE 进行了检索,共检索到 895 篇文章,其中 57 篇符合纳入标准。

结果

48 篇(84%)文章为队列研究,7 篇(12%)为病例对照研究,2 篇(4%)为横断面研究。研究人群从术后患者到内科患者不等。个体研究分配的 VTE 风险类别数量存在差异(6 项研究使用 5 个风险类别,37 项研究使用 4 个,11 项研究使用 3 个,3 项研究使用 2 个),并且风险类别的截止分数也存在差异(低风险类别为 0 分,0-10 分;高风险类别为 5 分及以上,10 分及以上)。类似风险类别的 VTE 发生率也因研究而异(低风险类别为 0%-12.3%;高风险类别为 0%-40%)。卡普里尼 RAM 旨在评估复合 VTE 风险;但是,有两项研究仅报告了 PE 或 DVT 发生率,许多其他研究未具体说明分析的 DVT 类型。卡普里尼 RAM 预测评估后 30 天的 VTE;但是,只有 17 项研究在 30 天内测量了结果;其余研究的随访时间更短或更长(0-180 天)。

结论

卡普里尼 RAM 的实用性受到其在各中心实施的异质性的限制。基于评分的 VTE 风险分类在使用的风险类别数量、用于定义风险类别的截止分数、测量的结果以及随访持续时间方面存在很大差异。这一因素导致相似的风险类别与不同的 VTE 发生率相关,从而影响了研究结果的临床和研究意义。为了提高通用性,需要在广泛的内科和外科患者群体中对 RAM 进行验证,确定标准化的风险类别,将 DVT 和 PE 的风险定义为不同的终点,并在标准化的随访时间点测量结果。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f7bf/9783939/02ce402306f1/nihms-1827626-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f7bf/9783939/3641cb18e8cb/nihms-1827626-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f7bf/9783939/02ce402306f1/nihms-1827626-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f7bf/9783939/3641cb18e8cb/nihms-1827626-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f7bf/9783939/02ce402306f1/nihms-1827626-f0002.jpg

相似文献

1
Systematic review of venous thromboembolism risk categories derived from Caprini score.基于 Caprini 评分的静脉血栓栓塞风险分类的系统评价。
J Vasc Surg Venous Lymphat Disord. 2022 Nov;10(6):1401-1409.e7. doi: 10.1016/j.jvsv.2022.05.003. Epub 2022 Aug 2.
2
Pharmacological interventions for preventing venous thromboembolism in people undergoing bariatric surgery.药物干预预防接受减重手术人群的静脉血栓栓塞症。
Cochrane Database Syst Rev. 2022 Nov 22;11(11):CD013683. doi: 10.1002/14651858.CD013683.pub2.
3
Interventions for implementation of thromboprophylaxis in hospitalized patients at risk for venous thromboembolism.对有静脉血栓栓塞风险的住院患者实施血栓预防的干预措施。
Cochrane Database Syst Rev. 2018 Apr 24;4(4):CD008201. doi: 10.1002/14651858.CD008201.pub3.
4
Antiplatelet agents for the treatment of deep venous thrombosis.抗血小板药物治疗深静脉血栓形成。
Cochrane Database Syst Rev. 2022 Jul 25;7(7):CD012369. doi: 10.1002/14651858.CD012369.pub2.
5
Home versus in-patient treatment for deep vein thrombosis.深静脉血栓形成的家庭治疗与住院治疗对比
Cochrane Database Syst Rev. 2018 Jan 9;1(1):CD003076. doi: 10.1002/14651858.CD003076.pub3.
6
Effect of testing for cancer on cancer- or venous thromboembolism (VTE)-related mortality and morbidity in people with unprovoked VTE.不明原因静脉血栓栓塞症(VTE)患者中,检测癌症对癌症或静脉血栓栓塞症(VTE)相关死亡率和发病率的影响。
Cochrane Database Syst Rev. 2021 Oct 1;10(10):CD010837. doi: 10.1002/14651858.CD010837.pub5.
7
Combined intermittent pneumatic leg compression and pharmacological prophylaxis for prevention of venous thromboembolism.联合间歇性气动腿部压迫和药物预防预防静脉血栓栓塞症。
Cochrane Database Syst Rev. 2022 Jan 28;1(1):CD005258. doi: 10.1002/14651858.CD005258.pub4.
8
The measurement and monitoring of surgical adverse events.手术不良事件的测量与监测
Health Technol Assess. 2001;5(22):1-194. doi: 10.3310/hta5220.
9
Home treatment for mental health problems: a systematic review.心理健康问题的居家治疗:一项系统综述
Health Technol Assess. 2001;5(15):1-139. doi: 10.3310/hta5150.
10
Interventions for preventing venous thromboembolism in adults undergoing knee arthroscopy.成人膝关节镜检查中预防静脉血栓栓塞症的干预措施。
Cochrane Database Syst Rev. 2022 Aug 22;8(8):CD005259. doi: 10.1002/14651858.CD005259.pub5.

引用本文的文献

1
Development and validation of a machine learning model for predicting venous thromboembolism complications following colorectal cancer surgery.用于预测结直肠癌手术后静脉血栓栓塞并发症的机器学习模型的开发与验证
Vis Comput Ind Biomed Art. 2025 Sep 12;8(1):22. doi: 10.1186/s42492-025-00204-y.
2
Development and validation of a machine learning-based early warning system for predicting venous thromboembolism risk in hospitalized lymphoma patients undergoing chemotherapy: a multicenter and retrospective cohort study.基于机器学习的住院化疗淋巴瘤患者静脉血栓栓塞风险预测预警系统的开发与验证:一项多中心回顾性队列研究
Front Oncol. 2025 Aug 12;15:1566905. doi: 10.3389/fonc.2025.1566905. eCollection 2025.
3

本文引用的文献

1
Venous thromboembolism risk stratification in trauma using the Caprini risk assessment model.创伤患者应用 Caprini 风险评估模型进行静脉血栓栓塞风险分层。
Thromb Res. 2021 Dec;208:52-57. doi: 10.1016/j.thromres.2021.10.016. Epub 2021 Oct 23.
2
Diagnostic Performance of the Caprini Risk Assessment Model Combined With D-Dimer for Preoperative Deep Vein Thrombosis in Patients With Thoracolumbar Fractures Caused by High-Energy Injuries.高能损伤致胸腰椎骨折患者术前深静脉血栓形成的 Caprini 风险评估模型联合 D-二聚体的诊断性能。
World Neurosurg. 2022 Jan;157:e410-e416. doi: 10.1016/j.wneu.2021.10.106. Epub 2021 Oct 19.
3
Predicting venous thromboembolism and determining appropriate prophylaxis in elderly patients undergoing colorectal cancer surgery with Enhanced Recovery After Surgery (ERAS) using the adjusted Caprini score.
使用调整后的Caprini评分预测接受结直肠癌手术并采用加速康复外科(ERAS)的老年患者的静脉血栓栓塞,并确定适当的预防措施。
Ann Coloproctol. 2025 Aug;41(4):279-286. doi: 10.3393/ac.2024.00857.0122. Epub 2025 Aug 26.
4
Comparative Analysis of Padua and Caprini Scores in Predicting Venous Thromboembolism Risk Among Nonagenarians: A Cross-Sectional Study From Rugao.帕多瓦评分与卡普里尼评分在预测非agenarians静脉血栓栓塞风险中的比较分析:一项来自如皋的横断面研究。 (注:这里“Nonagenarians”直译为“九十多岁的人”,结合语境在医学研究中可意译为“非agenarians”这种更专业表述,可根据具体需求进一步调整,这里先按字面直译呈现整体翻译内容)
Ann Noninvasive Electrocardiol. 2025 Sep;30(5):e70107. doi: 10.1111/anec.70107.
5
Combined assessment of Caprini score, D-dimer, and thromboelastography for predicting deep venous thrombosis in lung cancer patients.联合评估Caprini评分、D-二聚体和血栓弹力图以预测肺癌患者的深静脉血栓形成
Am J Cancer Res. 2025 Jul 15;15(7):3299-3309. doi: 10.62347/TOVV5723. eCollection 2025.
6
A Mendelian randomization study of the causal relationship between dietary factors and venous thromboembolism.一项关于饮食因素与静脉血栓栓塞症因果关系的孟德尔随机化研究。
Medicine (Baltimore). 2025 Aug 8;104(32):e43565. doi: 10.1097/MD.0000000000043565.
7
Analysis of risk factors and prediction model construction of deep vein thrombosis in patients with lumbar degenerative diseases before surgery.腰椎退变性疾病患者术前深静脉血栓形成的危险因素分析及预测模型构建
Sci Rep. 2025 Jul 18;15(1):26069. doi: 10.1038/s41598-025-10752-1.
8
Machine learning models predict risk of lower extremity deep vein thrombosis in hospitalized patients with spontaneous intracerebral hemorrhage.机器学习模型可预测自发性脑出血住院患者下肢深静脉血栓形成的风险。
Sci Rep. 2025 Jul 10;15(1):24932. doi: 10.1038/s41598-025-10905-2.
9
Predictive efficacy of rectus abdominis muscle and psoas major muscle thickness for postoperative morbidity in patients with endometrial cancer.腹直肌和腰大肌厚度对子宫内膜癌患者术后发病率的预测效能
J Turk Ger Gynecol Assoc. 2025 Jun 10;26(2):121-129. doi: 10.4274/jtgga.galenos.2025.2025-4-6.
10
Nurses' knowledge, attitudes, and practices regarding deep vein thrombosis and the nursing management.护士关于深静脉血栓形成及护理管理的知识、态度和实践。
Sci Rep. 2025 May 17;15(1):17174. doi: 10.1038/s41598-025-96551-0.
Evaluation of an Extended-duration Chemoprophylaxis Regimen for Venous Thromboembolism after Microsurgical Breast Reconstruction.
显微外科乳房重建术后静脉血栓栓塞症延长疗程化学预防方案的评估
Plast Reconstr Surg Glob Open. 2021 Aug 6;9(8):e3741. doi: 10.1097/GOX.0000000000003741. eCollection 2021 Aug.
4
Implementation of a Novel Protocol for Preventing Venous Thromboembolism in Otolaryngology Patients.实施耳鼻喉科患者静脉血栓栓塞预防的新方案。
Otolaryngol Head Neck Surg. 2022 Feb;166(2):297-304. doi: 10.1177/01945998211024923. Epub 2021 Jul 13.
5
Prognostic Value of Venous Thromboembolism Risk Assessment Models in Patients with Severe COVID-19.静脉血栓栓塞风险评估模型在重症新型冠状病毒肺炎患者中的预后价值
TH Open. 2021 Jun 22;5(2):e211-e219. doi: 10.1055/s-0041-1730293. eCollection 2021 Apr.
6
Prevalence and clinical outcomes of hospitalized patients with upper extremity deep vein thrombosis.上肢深静脉血栓形成住院患者的患病率和临床结局。
J Vasc Surg Venous Lymphat Disord. 2022 Jan;10(1):102-110. doi: 10.1016/j.jvsv.2021.05.007. Epub 2021 Jun 2.
7
Venous thromboembolism risk factors and prophylaxis of elderly intensive care unit patients in a Chinese general hospital.中国综合医院老年重症监护病房患者静脉血栓栓塞的危险因素及预防
Ann Palliat Med. 2021 Apr;10(4):4453-4462. doi: 10.21037/apm-21-464. Epub 2021 Apr 14.
8
Plasminogen activator inhibitor-1 gene promoter 4G/5G polymorphism and risks of peripherally inserted central catheter-related venous thrombosis in patients with lung cancer: a prospective cohort study.纤溶酶原激活物抑制剂-1 基因启动子 4G/5G 多态性与肺癌患者经外周中心静脉置管相关静脉血栓形成风险的前瞻性队列研究。
Support Care Cancer. 2021 Nov;29(11):6431-6439. doi: 10.1007/s00520-021-06207-8. Epub 2021 Apr 24.
9
Incidence and Risk Factors for Venous Thromboembolism Following 2462 Major Abdomino-Pelvic Surgeries in Tertiary Hospital.2462 例三级医院腹盆腔大手术后静脉血栓栓塞症的发生率及危险因素分析。
Vasc Health Risk Manag. 2021 Apr 8;17:135-143. doi: 10.2147/VHRM.S304187. eCollection 2021.
10
The PRISMA 2020 statement: an updated guideline for reporting systematic reviews.PRISMA 2020 声明:系统评价报告的更新指南。
BMJ. 2021 Mar 29;372:n71. doi: 10.1136/bmj.n71.